Rahul D. Ballal

Board Member

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

ELVN

Current role

Board Member, CEO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2023	Enliven Therapeutics, Inc. (ELVN)	Former President and Chief Executive Officer	$113,874	—	—	$499,889	—	$1,252,046	$1,865,809
2022	Enliven Therapeutics, Inc. (ELVN)	Former President and Chief Executive Officer	$547,917	$275,000	$181,332	$135,342	—	$10,090	$1,149,681
2021	Enliven Therapeutics, Inc. (ELVN)	President and Chief Executive Officer	$517,729	$232,978	—	$1,189,482	—	$10,840	$1,951,029
2020	Enliven Therapeutics, Inc. (ELVN)	President and Chief Executive Officer	$436,687	$177,289	—	—	—	$11,620	$625,596
2019	Enliven Therapeutics, Inc. (ELVN)	President and Chief Executive Officer	$421,806	$153,000	—	$1,446,110	—	$5,453	$2,026,369

No earnings-call appearances or filed executive changes recorded yet.